Public and private M&A

easyHotel

Advised easyHotel on its £139 million takeover.

BTG plc

Advised on the £177 million takeover of Biocompatibles plc.

Kalibrate

Advised Kalibrate Technologies on its £29 million takeover by Hanover Active Equity Fund.

Whitewash and advisory

Advised on various Code whitewashes and advisory work.

De Vere

Advised on the sale of the Grand Hotel, Brighton.

Feedback plc

Advised Feedback plc on acquisitions of Cambridge Computed Images Ltd and TexRAD Ltd.

AIM Group Ltd

Sale of US operations and UK holding company of aviation manufacturing company to buyer backed by Liberty Hall Capital for US$220 million.

AIM Group Plc

Advised on the sale of this specialist manufacturer of aircraft interiors to management, backed by Lloyds Development Capital

Restructuring and insolvency

Gentoo Group

Advised on its acquisition of the assets of AIM listed Romag Holdings plc by way of a pre-pack administration.

The Pension Protection Fund

Advised on various matters including the restructuring of Monarch Airlines.

BTG plc

Advised in relation to the pre-pack acquisition of certain assets of SCM Pharma.

Joint ventures

JP Morgan

Advised JP Morgan on its container ship joint venture with global shipping company Bernhard Schulte.

Maas Capital

Advised in relation to a joint venture in the offshore sub sector.

International shipowner

Advised on its entry into and exit from a VLGC owning joint venture.

Equity capital markets

Manolete Partners

Advised Manolete Partners on its £76m AIM IPO and placing.

BTG

Advised BTG plc on its £160m joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc.

Numis and Hornby

Advised Numis in relation to Hornby’s placing and move from the main market to AIM.

Novacyt

Advised Paris-listed medical diagnostics company Novacyt on its dual listing on AIM.

Hotel Chocolat

Advised Hotel Chocolat on its AIM IPO and secondary fundraising.

Northland

Advised Northland on its role as Nomad to Evgen Pharmaceuticals on its AIM IPO.

Numis and Argentex Group

Advised Numis in its role as nominated adviser and broker on the AIM IPO of Argentex Group plc and related £46 million placing of new and existing shares.

easyHotel plc

Advised easyHotel on its AIM IPO, subsequent secondary fundraisings, takeover and de-listing.

finnCap

Advised finnCap on its role as Nomad and broker to KRM22 on its AIM IPO.

NetScientific

Advised NetScientific plc on its acquisition of EMV Capital Limited and placing, including a Rule 9 waiver.

Oriel

Advised Oriel in its role as Nomad and broker to Rex Bionics, provider of electronic mobility devices, in relation to an acquisition and its re-admission to AIM.

Corporate

BTG plc

Advised BTG plc on the joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc.

Advised BTG plc on the £177 million takeover of Biocompatibles plc.

De Vere

Advised De Vere on the sale of the Grand Hotel, Brighton.

Numis Securities

Advised Numis Securities in relation to Hornby plc's placing and move from the main market to AIM.

Kalibrate Technologies plc

Advised Kalibrate Technologies plc on its admission to trading on AIM.

Life sciences

Tom is a corporate lawyer with particular experience in the life sciences sector. He advises on equity capital markets transactions, including IPOs and secondary fundraisings, private M&A and public takeovers. Tom acts for private and listed companies and for life sciences teams at brokers and investment banks. Clients value Tom’s pragmatic and commercial approach and his ability to guide them smoothly through transactions.

Tom’s life sciences experience includes advising:

BTG

Advised in relation to its joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc

Novacyt SA

Advised Novacyt SA, a French incorporated diagnostics company with HQ in the UK, on its AIM IPO which constituted a dual listing with the existing listing on Euronext Growth Paris

Northland Capital Partners

Advised in its role as Nomad and broker to Evegen Pharma on its AIM IPO

A FTSE 250 healthcare company

Advised in relation to a private acquisition of a university spin out.

Multi-jurisdictional joint venture

Advised in relation to a multi-jurisdictional joint venture over Finnish pharmaceuticals company

Oriel

Advised in its role as Nomad and broker to Rex Bionics, provider of electronic mobility devices, in relation to an acquisition and re-admission to AIM

BTG

Advised on the pre-pack acquisition of assets of SCM Pharma

BTG

Advised on its £177 million takeover of Biocompatibles plc by way of scheme of arrangement

NetScientific

Advised on its acquisition, placing and Rule 9 waiver

More: Life sciences

Technology

Kalibrate Technologies Plc

Advised in connection with AIM IPO of Kalibrate Technologies Plc, a provider of proprietary software-based products and services to the global petroleum retail industry, and in connection with its subsequent recommended takeover.

Nomad

Advised Nomad in connection with acquisition and readmission to AIM of Rex Bionics, pioneer of the REX Robot technology that enhances the mobility of wheel-chair users and on its subsequent secondary placing.

Nomad

Advised Nomad and joint brokers in connection with AIM IPO of BPO company, Ibex Global Solutions.

More: Technology